Abbott introduces its FDA-approved TactiFlex Duo ablation catheter
The sensor-enabled device delivers precision and flexible treatment options for patients seeking minimally invasive solutions for atrial fibrillation.
Latest Abbott News & Updates
See the latest news and media coverage for Abbott. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global healthcare products and technologies company
abbott.com- Headquarters
- Abbott Park, United States
- Company type
- Public company
- Number of employees
- 150,000+
Last updated
Latest news about Abbott
In short: Abbott received key device approvals for heart and diabetes care and settled long-running infant formula litigation for $670 million.
Company announcements
Abbott presents positive 12-month results for its AFib device
The TactiFlex Duo combines pulsed field and radiofrequency ablation. Trial data show 92.6% patients remained arrhythmia-free at follow-up, with a 98.3% safety profile and no major adverse events.
Abbott receives CE Mark for next-generation Amulet 360 device
Designed to seal the heart's left atrial appendage, the device reduces stroke risk without long-term blood thinners, backed by high closure rates from the VERITAS clinical trial.
Abbott's partner Freenome gets FDA approval for SimpleScreen
The test provides another screening option for up to 60 million unscreened eligible Americans, complementing existing Cologuard tests.
Media coverage
Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm
By Connor Hart Abbott Laboratories said it received FDA approval for its TactiFlex Duo Ablation...
Valid Regs Require Abbott To Pay Tax On $8B Gain, IRS Says - Law360 Tax Authority
The IRS urged the U.S. Tax Court to validate regulations that the agency said required Abbott Laboratories to pay taxes on an $8 billion gain...
ESC 2026: Abbott presents positive longer-term dual ablation catheter data
Abbott's TactiFlex Duo provides pulsed-field ablation and radiofrequency to offer greater flexibility in treating atrial fibrillation.
What Does Abbott Laboratories (ABT) FDA Clearance Mean For Its Diabetes Device Push?
Abbott Laboratories (NYSE:ABT) received FDA De Novo authorization for its Libre Duo 10 Day,...
Never miss news about Abbott
Track Abbott and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Abbott competitors & trending companies
Browse news for competitors to Abbott and other trending companies.
Medtronic
Boston Scientific
BD
J&J
ManpowerGroup
Arcosa
Alliance Entertainment
QXO
Reliant Stones
Amber
The Pool Tile Co
Cinajus
Armstone
Eco Outdoor
Sareen Stone
Stone Planet
Salience Labs
Trio Petroleum
Arianespace
American Eagle
AEO
OLB
Compass
MAQS
Roschier
Möller & Partners
Normain
Incentive Industrier
Pinecone
SSHL
Videobuddy
Founders Alliance
ITT
ServiceTitan